Medicare Enrolled
Dr. Sohail Jalal, MD
Cardiovascular Disease · Houston, TX
Practice pattern: Remote & Electrophysiology— Practice combining remote and electrophysiology services
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jalal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jalal? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Jalal
Dr. Sohail Jalal is a cardiovascular disease in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Jalal performed 10,606 Medicare services across 3,732 unique beneficiaries.
Between the years covered by Open Payments, Dr. Jalal received a total of $67,474 from 31 pharmaceutical and/or device companies across 734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Jalal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 3% volume in TX$ $67,474 industry payments
Medicare Practice Summary
Medicare Utilization ↗10,606
Medicare services
Top 3% in TX for cardiovascular disease
3,732
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~530 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 2,102 | $27 | $37 |
| Remote pacemaker/defibrillator monitoring, 90 days | 1,365 | $16 | $27 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 1,069 | $18 | $28 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 1,037 | $19 | $29 |
| Remote pacemaker monitoring, 90 days | 937 | $21 | $35 |
| Office visit, established patient (30-39 min) | 769 | $95 | $134 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 428 | $26 | $69 |
| Programming of dual lead pacemaker system | 415 | $27 | $42 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician only | 308 | $5 | $8 |
| Office visit, established patient, complex (40-54 min) | 273 | $137 | $205 |
| Evaluation of implantable heart and blood vessel monitoring system | 227 | $17 | $23 |
| Evaluation of cardiac rhythm monitor system | 209 | $13 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 144 | $10 | $13 |
| Ultrasonic guidance for blood vessel access | 134 | $11 | $15 |
| Electrocardiogram (EKG), 12-lead | 129 | $10 | $15 |
| Electrocardiogram (ecg) 1 to 3 leads with review by physician | 129 | $9 | $13 |
| Programming of multiple lead implantable defibrillator system | 124 | $45 | $66 |
| Initial hospital admission, high complexity | 119 | $133 | $210 |
| Programming of dual lead implantable defibrillator system | 91 | $40 | $96 |
| Hospital follow-up visit, high complexity | 79 | $84 | $108 |
| New patient office visit, complex (60-74 min) | 67 | $167 | $230 |
| New patient office visit (45-59 min) | 52 | $128 | $190 |
| Insertion of heart rhythm monitor under skin | 43 | $3,512 | $4,881 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 37 | $416 | $588 |
| Programming of heart rhythm stimulation after drug infusion | 37 | $66 | $116 |
| Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation | 36 | $767 | $1,154 |
| Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm | 33 | $249 | $350 |
| Insertion of catheters and destruction of tissue to treat abnormal heart rhythm | 27 | $250 | $351 |
| Repair of left upper heart chamber with implant with review by radiologist | 21 | $566 | $920 |
| Evaluation of single or dual chamber pacing cardioverter-defibrillator and generator at time of implantation or replacement | 18 | $123 | $162 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 17 | $672 | $1,025 |
| Programming of single lead pacemaker system | 17 | $19 | $33 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 17 | $16 | $20 |
| Office visit, established patient (20-29 min) | 17 | $64 | $95 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 16 | $19 | $27 |
| Removal and replacement of dual lead permanent pacemaker | 14 | $279 | $375 |
| Injection for x-ray imaging procedure into vein of arm or leg | 13 | $21 | $50 |
| Removal of heart rhythm monitor from under the skin | 12 | $38 | $171 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 12 | $40 | $128 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $91 | $126 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
33.4% high complexity
0.1% medium
66.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$67,474
Total received (2018-2024)
Avg $9,639/year across 7 years
Top 9% in TX for cardiovascular disease
31
Companies
734
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$25,231 (37.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,844 (36.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$17,400 (25.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,884
2023$4,251
2022$3,188
2021$2,019
2020$4,310
2019$12,665
2018$39,157
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$27,184
Janssen Pharmaceuticals, Inc
$25,246
Medtronic, Inc.
$3,032
BIOTRONIK INC.
$2,859
BOSTON SCIENTIFIC CORPORATION
$2,095
Boston Scientific Corporation
$1,742
Medtronic Vascular, Inc.
$817
Biosense Webster, Inc.
$711
Novartis Pharmaceuticals Corporation
$594
SANOFI-AVENTIS U.S. LLC
$457
E.R. Squibb & Sons, L.L.C.
$379
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$336
Merck Sharp & Dohme LLC
$325
Inspire Medical Systems, Inc.
$317
Preventice Services, LLC
$254
CARDIVA MEDICAL, INC.
$252
CardioFocus, Inc.
$219
ABIOMED
$149
PFIZER INC.
$69
Aziyo Biologics, Inc.
$59
AstraZeneca Pharmaceuticals LP
$54
AGEPHA Pharma FZ LLC
$53
Amarin Pharma Inc.
$48
AltaThera Pharmaceuticals LLC
$40
Medtronic USA, Inc.
$40
Bardy Diagnostics, Inc.
$33
Terumo Medical Corporation
$31
ZOLL Respicardia, Inc.
$30
Lundbeck LLC
$22
AngioDynamics, Inc.
$17
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 82.2% of total payments
Associated products mentioned in payments ›
ADVISOR · ALLURE · AMPLATZER AMULET · AMPLATZER Occluders · ASSURITY · ATTAIN COMMAND + SUREVALVE · AVEIR · AZURE XT DR MRI SURESCAN · Ablation Therapy Hardware · Acticor · Acticor 7 VR-T DX · Advisa · Advisor Catheter · Allure CRT Pacemaker · Amplia MRI · Arctic Front · Assurity Pacemaker · Attain · Azure · BG Mini Plus · BIOMONITOR · BRILINTA · BioMonitor · BodyGuardian · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · CRT-Ds · Cardiac Mapping System · CareLink · Carnation Ambulatory Monitor · Carto 3 · Confirm Rx · Connectivity and Remote care · CryoConsole · DYNAGEN · ECM Patch · ELIQUIS · EMBLEM · EMBLEM MRI S-ICD · EMBLEM SICD ELECTRODE DELIVERY SYSTEM · EMPLICITI · ENSITE PRECISION · ENTRESTO · EP-Research Only · Edora · Edora 8 DR-T · Ellipse ICD · Ensite Cardiac Mapping System · Evera · FARXIGA · Fortify Assura · GALLANT · GENERAL TACHY · GENERAL - BRADY · GENERAL TACHY · GENERAL THERAPIES · General - Therapies · I-STAT · ICDs · INGEVITY MRI · INSPIRE · Impella · Inspire Upper Airway Stimulation System · LATITUDE · LATITUDE Communicator Power Supply · LINQ II · LODOCO · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MERLIN@HOME · MICRA · MRI Ready Leads · MULTAQ · MYCARELINK · Merlin Connectivity and Remote · Micra · NA · NORTHERA · PRALUENT · PULSESELECT · Pacemakers · PlasmaBlade · Pouch · Quadra Allure MP RF CRT Pacemkr · Quadra Assura CRT Defibrillator · Quartet CRT Lead · RESONATE · REVEAL LINQ · Reflexion Circular Mapping Cath · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S ICD · S-ICD System Magnet · SELECTSECURE · SQ-RX PULSE GENERATOR · SUPERA · SelectSecure · Solia · Sotalol Hydrochloride · TactiCath Quartz CFA Catheter · Tendril Pacing Lead · VADO · VERQUVO · VIGILANT · Vascepa · Visia AF · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (37%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 9% for cardiovascular disease in TX.
Equivalent to $636 per 100 Medicare services performed
Geographic Context
Cardiovascular Diseases within 10 mi
392
Per 100K population
8.2
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Jalal is a remote & electrophysiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (mixed engagement, top 9%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Jalal experienced with interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec?
Based on Medicare claims data, Dr. Jalal performed 2,102 interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jalal receive payments from pharmaceutical companies?
Yes. Dr. Jalal received a total of $67,474 from 31 companies across 734 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jalal's costs compare to other cardiovascular diseases in Houston?
Dr. Jalal's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jalal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiovascular Diseases in Houston
Browse cardiovascular diseases in Houston ranked by procedure volume and transparency data.
Highest volume
Top Cardiovascular Diseases in TX
Cardiovascular Diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiovascular Diseases in TX
Which TX cardiovascular diseases receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology